# Regal Healthcare Capital Partners

> Regal Healthcare Capital Partners is a New York control growth equity and buyout firm focused exclusively on smaller lower-middle-market healthcare services businesses. Founded in 2018 by physician-operator David Kim and healthcare banker Jon Santemma, Regal backs provider-led, multi-site companies and pairs capital with hands-on work in analytics, staffing, clinic expansion, provider incentives and patient experience. Its four funds have attracted nearly $1.3 billion in aggregate commitments, including a $610 million Fund IV closed in July 2026.

- **Founded:** 2018
- **Headquarters:** New York, United States
- **Founders:** David Kim, MD, MBA (Co-Founder and General Partner), Jon Santemma, JD, MBA (Co-Founder and General Partner)
- **Team size:** Approximately 30 people; LinkedIn showed 32 employee profiles in 2026, while company-size labels and third-party counts vary.
- **Products:** Control growth equity and buyout investing, Operational value creation, Provider and patient alignment, RHCP IV
- **Notable:** Closed Fund IV at $610 million in July 2026, above its original $550 million target., Raised nearly $1.3 billion in aggregate commitments across four funds since 2018., Closed the $415 million Fund III at its hard cap in 2021 after raising it in less than one month.

## Products & services

- **Control growth equity and buyout investing** — Equity capital for smaller lower-middle-market healthcare services businesses, especially provider-led and multi-site companies in fragmented sectors.
- **Operational value creation** — Support spanning data analytics, KPI dashboards, process engineering, staffing forecasts, clinic-site selection and waste reduction.
- **Provider and patient alignment** — Operating programs focused on clinical leadership, provider incentives, training, scheduling access, visit times, communications and patient satisfaction.
- **RHCP IV** — Regal's fourth closed-end healthcare private equity fund, with $610 million in total commitments for its established healthcare services strategy.

## Achievements

- Closed Fund IV at $610 million in July 2026, above its original $550 million target.
- Raised nearly $1.3 billion in aggregate commitments across four funds since 2018.
- Closed the $415 million Fund III at its hard cap in 2021 after raising it in less than one month.
- Was selected for Inc. Magazine's Founder-Friendly Investors list in 2022 and 2023; Regal disclosed that applicants paid a fee for consideration.
- Helped grow Dental365 to nearly 70 locations and more than 400,000 annual patient visits before its announced 2021 sale to The Jordan Company.
- Had partnered with founders of 13 healthcare services businesses by November 2023.

## Latest updates

- **2026-07** — Closed RHCP IV at $610 million in total commitments, including about $575 million of external commitments, above a $550 million target.
- **2023-11** — Selected for Inc. Magazine's Founder-Friendly Investors list for a second consecutive year.
- **2022-06** — Formed InFocus Eyecare with executive Ryan Williams, funded from Fund III.
- **2021-11** — Closed Fund III at its $415 million hard cap.
- **2021-07** — Thriveworks added Wellington Management and other investors while Regal remained its largest equity holder; Dental365 announced a sale to The Jordan Company.

## Links

- Website: https://www.regalhcp.com/
- LinkedIn: https://www.linkedin.com/company/regal-healthcare-capital-partners

---

Profile page: https://yespress.io/regal-healthcare-capital-partners
Published by YesPress — https://yespress.io
Last updated: 2026-08-16